Evidence map›Paper›PMID 27330799›Full record

ArticleMolecular and clinical oncology2016

Esophageal metastasis secondary to extranodal nasal-type natural killer/T-cell lymphoma: A case report.

Zheng-Ying Mo, Ping Wang, Hong-Wei Yang, Wen-Bin Li, Qing-LE Liang

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Natural killer/T-cell lymphoma invading the orbit and globe.Proceedings (Baylor University. Medical Center) · 2017
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zheng-Ying MoDepartment of Oncology, Tai-He Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Ping WangDepartment of Radiology, Ren-Ming Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Hong-Wei YangDepartment of Clinical Laboratory, Tai-He Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Wen-Bin LiDepartment of Clinical Laboratory, Tai-He Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Qing-LE LiangDepartment of Clinical Laboratory, Tai-He Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Hubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of recurrent nasal natural killer (NK)/T-cell lymphoma in a 21-year-old male patient. The patient presented with an esophageal mass, fever and difficulty in swallowing. There were no other obvious sites of recurrence apart from the esophageal lesion. Metastatic esophageal lesions are extremely rare. The histological analysis demonstrated a highly aggressive tumor with a characteristic angiodestructive growth pattern and nasal cavity necrosis. The lymphoma cells were immunopositive for leukocyte common antigen, T-cell intracytoplasmic antigen 1 and CD68, negative for CD56 and CD3, and positive for Epstein-Barr virus. A computed tomography scan revealed mild thickening of the wall of the lower esophagus. The barium swallow revealed stiffness of the esophageal wall, with limited expansion and mucosal damage. The final diagnosis was primary nasal NK/T-cell lymphoma, with metastasis to the esophagus. Clinically, it is important to distinguish nasal-type NK/T-cell lymphoma from other types of tumors, as its prognosis and treatment of secondary metastases differ significantly.

Indexed as

distant metastasisextranodal typenatural killer/T-cell lymphoma

Identifiers

PMID27330799
PMCPMC4906825
OpenAlexW2338808817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.